A cornerstone of former President Trump’s defense strategy appears to be delaying trials until after the November election. Robert Mintz spoke with Axios about this tactic and what it could mean for the future of the litigations. Continue Reading
Hytera Sanctions Show Strength Of Antisuit Injunctions
The Seventh Circuit recently decided to uphold $1 million a day in sanctions against a manufacturing company for violating an order to drop trade secrets and copyright litigation in China. The manufacturer amassed $14 million in potential fines before the court stayed the sanctions after the company Continue Reading
Biden’s AI Guidance for Gov’t May Need More Risk Controls
In an effort to regulate use of emerging technology, the General Services Administration recommended that agencies looking into buying generative AI services and related hardware should weigh its benefits. Alex Major, Co-Chair of McCarter’s Government Contracts & Global Trade Practice, spoke Continue Reading
Are Nonprofit Hospitals Immune to FTC’s Non-compete Ban?
The FTC final rule, which forbids new non-compete contracts and bans organizations from enforcing existing non-competes with only a few exceptions, takes effect 120 days after its April 30th publication in the Federal Register. McCarter & English Partner Khaled Klele spoke with Fierce Healthcare Continue Reading
Appellate Panel Gives Town’s Cannabis Objectors Another Day in Court
A New Jersey appeals court has ordered the reinstatement of a lawsuit over plans to let cannabis retailers, consumption lounges, and delivery services operate in Highland Park, NJ, giving local residents another chance to state their objections. The appellate court also affirmed a decision by Continue Reading
Cannabis Industry Reacts to DEA Rescheduling
The DEA has agreed to reschedule cannabis from a Schedule I to a Schedule III narcotic. While some legal professionals and advocacy groups within the industry consider this a move in the right direction, others have expressed concerns over the reclassification’s impact on equity, social justice, and Continue Reading
Biden Administration Just Took Huge Step to Reclassify Weed. Here’s What It Means for N.J.
In a major move, President Joe Biden’s administration plans to reclassify weed as a less harmful substance, which could lay the groundwork for more medical research and help cannabis businesses in New Jersey and beyond. Citing sources, the Associated Press reported that the U.S. Drug Enforcement Continue Reading
Court Says Chubb’s Bid to Deny Sex-Abuse Coverage for Archdiocese of New York May Advance
A New York state appeals court has reversed a lower-court ruling that dismissed an insurer’s lawsuit in a case involving liabilities related to sex-abuse claims against the Archdiocese of New York. Sheri Pastor, Chair of McCarter’s Insurance Recovery Practice, spoke with The Wall Street Journal and Continue Reading
Noncompete Decision: N.J. Lawyers Express Some Concern — And a Lot of Caution
The Federal Trade Commission’s ban of most noncompete agreements has the business community on edge with the ruling set to go into effect in 120 days. Hugh Murray, Chair of McCarter’s Labor & Employment Practice spoke with ROI-NJ about the ruling and offered a bit of advice for business owners. Continue Reading
4 Things Attys Should Know about NJ’s $56B Spending Plan
New Jersey Governor Phil Murphy has created a spending plan that furthers his vision of making the state an innovator in offshore wind and AI. Also part of the spending plan is a proposed corporate transit fee and warehouse tax that has raised concerns among business groups across the state. Continue Reading